000710 貝瑞基因
按盤價 
8.710 +0.790 (+9.975%)
8.710 +0.790 (+9.975%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.496 | -20.512 | -10.403 | -4.789 | 8.932 |
| 總資產報酬率 ROA (%) | 0.328 | -14.372 | -7.411 | -3.453 | 6.674 |
| 投入資產回報率 ROIC (%) | 0.384 | -16.689 | -8.587 | -3.994 | 7.738 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.195 | 44.745 | 42.716 | 44.735 | 52.625 |
| 營業利潤率 (%) | 3.931 | -39.147 | -20.469 | -8.244 | 15.916 |
| 息稅前利潤/營業總收入 (%) | 4.604 | -38.117 | -18.921 | -7.814 | 16.877 |
| 淨利潤/營業總收入 (%) | 2.187 | -36.934 | -18.012 | -8.136 | 13.353 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 206.817 | 11.466 | 18.069 | 9.740 | 92.812 |
| 價值變動淨收益/利潤總額(%) | -24.555 | 13.632 | 52.214 | 38.604 | 16.873 |
| 營業外收支淨額/利潤總額(%) | -4.182 | 0.591 | -1.317 | 7.868 | 0.075 | 償債能力分析 |
| 流動比率 (X) | 1.585 | 1.930 | 2.450 | 2.472 | 3.609 |
| 速動比率 (X) | 1.372 | 1.630 | 2.123 | 2.167 | 3.285 |
| 資產負債率 (%) | 34.281 | 30.883 | 27.288 | 28.345 | 0.253 |
| 帶息債務/全部投入資本 (%) | 23.440 | 17.897 | 16.248 | 15.759 | 14.988 |
| 股東權益/帶息債務 (%) | 319.836 | 448.824 | 506.053 | 525.719 | 560.463 |
| 股東權益/負債合計 (%) | 188.321 | 220.188 | 263.266 | 249.427 | 290.734 |
| 利息保障倍數 (X) | 5.542 | -30.192 | -14.764 | -6.891 | 17.774 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 275.768 | 291.137 | 283.014 | 274.196 | 223.209 |
| 存貨周轉天數 (天) | 147.854 | 130.215 | 106.769 | 94.847 | 148.519 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
